Pages that link to "Q46210070"

The following pages link to Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests (Q46210070):

Displaying 26 items.

• Using biomarkers as objective standards in the diagnosis of cervical biopsies (Q30431203) (← links)
• Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia (Q33978458) (← links)
• p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis (Q34344782) (← links)
• Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa (Q34412349) (← links)
• Biomarkers of cervical dysplasia and carcinoma (Q35495173) (← links)
• Novel p16 binding peptide development for p16-overexpressing cancer cell detection using phage display (Q35574209) (← links)
• A prospective randomized study on limits of colposcopy and histology: the skill of colposcopist and colposcopy-guided biopsy in diagnosis of cervical intraepithelial lesions (Q36301978) (← links)
• p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing (Q36934218) (← links)
• Early detection of cervical carcinomas: finding an overall approach (Q37188108) (← links)
• Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2 (Q37223672) (← links)
• Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears (Q37406155) (← links)
• p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis (Q37406427) (← links)
• Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections (Q37998530) (← links)
• New technologies and procedures for cervical cancer screening (Q38064058) (← links)
• Understanding HPV tests and their appropriate applications (Q38133612) (← links)
• The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments (Q38205174) (← links)
• Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer (Q42245758) (← links)
• Immunohistochemical expression of p16 and HPV L1 capsid proteins as predictive markers in cervical lesions (Q42248567) (← links)
• Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial (Q42872486) (← links)
• Visual screening for early detection of cervical neoplasia in Angola (Q43009053) (← links)
• HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome (Q43710001) (← links)
• A comparison of human papillomavirus testing of clinician‐collected and self‐collected samples during follow‐up after screen‐and‐treat (Q46837519) (← links)
• Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. (Q53064581) (← links)
• P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies (Q81765423) (← links)
• Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results (Q84554685) (← links)
• The effect of p16/Ki-67 and p16/mcm2 on the detection of cervical intraepithelial neoplasia: a prospective study from China (Q92715507) (← links)